Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 12,344.00
Ask: 12,346.00
Change: 68.00 (0.55%)
Spread: 2.00 (0.016%)
Open: 12,268.00
High: 12,388.00
Low: 12,256.00
Prev. Close: 12,264.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Oil steadies as COVID-19-induced demand worries persist

Thu, 28th Jan 2021 05:31

* Delays with coronavirus vaccines in EU fuels demand
concerns

* China limits Lunar New Year trips as COVID cases rise

* Dollar gains on safe-haven bids, pressuring oil prices
(Updates prices)

By Ahmad Ghaddar

LONDON, Jan 28 (Reuters) - Oil steadied on Thursday after
early declines fuelled by delays to vaccine rollouts and fresh
travel curbs to prevent new coronavirus outbreaks.

Brent crude futures were up 8 cents, or 0.1%, at
$55.89 a barrel by 1331 GMT, having hit a session low of $55.31.

U.S. West Texas Intermediate (WTI) crude futures were
down 8 cents, or 0.2%, at $52.77 after dropping as low as
$52.22.

Oil prices were supported by data on Wednesday showing a
huge 10 million barrel decline in U.S. crude inventories last
week, which analysts said was because of a pick-up in U.S. crude
exports and a drop in imports.

But attention is returning to demand as contagious variants
drive a rise in coronavirus infections and a slower rollout of
vaccines in Europe and travel curbs in China are expected to
limit fuel consumption.

"Any sort of demand-related optimism remains on pause amid
the continued rise of new COVID-19 cases across key demand
centres and restricted mobility and public activity,"
consultants JBC Energy said.

Stricter vaccine checks by the European Union and delivery
hold-ups from AstraZeneca and Pfizer have slowed
the rollout of shots.

Adding to the bearishness over demand, China, the world's
second-largest oil consumer, faces a surge in coronavirus cases
and is seeking to limit travel as it heads into what is normally
the busiest travel season of the year, the Lunar New Year
holiday.

The Chinese Ministry of Transport has forecast the number of
trips that will be taken will rise 15% from last year, when the
virus was raging, but is still likely to be down 40% from 2019.

A strengthening dollar also weighed on prices. Buyers
using other currencies must pay more for dollar-denominated oil
when the greenback rises.

Data out later on Thursday is expected to show the economy
of the United States, the world's biggest oil user, contracted
in 2020 at its sharpest pace since 1946 because of the
pandemic.
(Additional reporting by Shu Zhang in Singapore and Sonali Paul
in Melbourne
Editing by Barbara Lewis and David Goodman
)

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.